Osteopontin expression in salivary gland carcinomas

Journal of Oral Pathology and Medicine

Volumn 40, Issue 6, 2011, Pages 451-455

  Bjrndal, Kristine ^a   Larsen, Stine R ^a   Godballe, Christian ^a   Krogdahl, Annelise ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Immunohistochemistry; Osteopontin; Prognostic factors; Salivary gland carcinomas

Indexed keywords

OSTEOPONTIN;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SCHOOL CHILD; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; OSTEOPONTIN; PROGNOSIS; SALIVARY GLAND NEOPLASMS; YOUNG ADULT;

EID: 79959927248     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00964.x     Document Type: Article

References (17)

1. Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res 2004; 121: 228-41.
2. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004; 90: 1877-81.
3. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16: 79-87.
4. Tuck AB, Chambers AF. The role of osteopontin in breast cancer: clinical and experimental studies. J Mammary Gland Biol Neoplasia 2001; 6: 419-29.
5. Kim JH, Skates SJ, Uede T, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002; 287: 1671-9.
6. Hu Z, Lin D, Yuan J, et al. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res 2005; 11: 4646-52.
7. Donati V, Boldrini L, Dell'Omodarme M, et al. Osteopontin expression and prognostic significance in non-small cell lung cancer. Clin Cancer Res 2005; 11: 6459-65.
8. Forootan SS, Foster CS, Aachi VR, et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2006; 118: 2255-61.
9. Barnes L, Eveson JW, Reichart P, Sidransky D. Tumours of the salivary glands. World health organization classification. Pathology and genetics of head and neck tumours. Lyon, France: IARC Press, 2005.
10. Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004; 10(1 Pt 1):184-90.
11. Darling MR, Gauthier M, Jackson-Boeters L, Daley TD, Chambers AF, Tuck AB. Osteopontin expression in salivary gland tumours. Oral Oncol 2006; 42: 363-9.
12. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-6.
13. Brown LF, Berse B, Van de WL, et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3: 1169-80.
14. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Expression of bone matrix proteins, osteonectin and osteopontin, in salivary pleomorphic adenomas. Pathol Res Pract 1999; 195: 733-9.
15. Petrik D, Lavori PW, Cao H, et al. Plasma osteopontin is an independent prognostic marker for head and neck cancers. J Clin Oncol 2006; 24: 5291-7.
16. Le QT, Sutphin PD, Raychaudhuri S, et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res 2003; 9: 59-67.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.